M Masquelier - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Masquelier

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Clinical Pharmacology and Therapeutics|July 30, 2010

Clinically significant CYP2C inhibition by noscapine but not by glucosamineS Rosenborg, M Stenberg, S Otto, et al.

European Journal of Medicinal Chemistry|June 20, 2000

Plasma stability and cytotoxicity of lipophilic daunorubicin derivatives incorporated into low density lipoproteinsM Masquelier, G Tirzitis, C O Peterson, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990

Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapyS Vitols, B Angelin, S Ericsson, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Clinical Pharmacology and Therapeutics|July 30, 2010

Clinically significant CYP2C inhibition by noscapine but not by glucosamineS Rosenborg, M Stenberg, S Otto, et al.

European Journal of Medicinal Chemistry|June 20, 2000

Plasma stability and cytotoxicity of lipophilic daunorubicin derivatives incorporated into low density lipoproteinsM Masquelier, G Tirzitis, C O Peterson, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990

Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapyS Vitols, B Angelin, S Ericsson, et al.

Pageof 3